Jennifer L. Carter serves as Executive at Oncocyte Corp, where they oversee executive responsibilities. Since joining the company, Jennifer L. Carter has executed 3 insider transactions totaling $10.0K, demonstrating a bullish approach to their equity position. Their most recent transaction on Aug 16, 2022 involved purchasing 10,500 shares valued at $10.0K.
Jennifer L. Carter currently holds 30,500 shares of Oncocyte Corp (OCX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jennifer L. Carter has been a net buyer of OCX stock. They have purchased $10.0K and sold $0 worth of shares.
Jennifer L. Carter's most recent insider trade was on Aug 16, 2022, when they purchased 10,500 shares at $0.95 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jun 24, 2022 | OCX | $0 | Option Exercise | 10,000 | $N/A | Discretionary |